News | June 01, 2026
Indoco's formulation plant at Baddi receives EU GMP certification
This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive
This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
The transaction marks a clear portfolio reshuffle for Indoco
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
The approved Lacosamide Oral Solution is bioequivalent and therapeutically equivalent to the reference drug and will be manufactured at Indoco’s facility in Verna Industrial Area, Goa
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
The inspection concluded with zero form 483 observations
Rivaroxaban is used to treat venous thromboembolism
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
Allopurinol is used to prevent or lower high uric acid levels in the blood
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
